Drugs / BT061
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01481493 | Dec 2010 → Aug 2013 | rheumatoid arthritis | Biotest | Completed | No outcome recorded |
| Phase 2 | NCT01072383 | Feb 2010 → Jun 2011 | psoriasis | Biotest | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BT061 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01072383 ↗ |
| Modality | Monoclonal antibody | “Humanized Monoclonal Antibody” NCT01072383 ↗ |
| Route | Intravenous | “either intravenous or subcutaneous” NCT01072383 ↗ |
| Route | Subcutaneous | “either intravenous or subcutaneous” NCT01072383 ↗ |